| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |